Skip to main content

News

By Jonah Comstock | 06:02 pm | January 25, 2017
On Tuesday, Representative Tom Price, President Trump’s pick for Secretary of Health and Human Services, faced his second confirmation hearing, this time before the Senate Finance Committee (previously he had gone before the Health committee).
By Jonah Comstock | 05:06 pm | January 25, 2017
Some of the biggest unsung challenges inherent in disrupting an industry are infrastructure and ecosystem challenges.
By Heather Mack | 05:05 pm | January 25, 2017
Pediatricians administering vaccines may try direct their young patients’ attention to colorful posters or don a puppet to get them focused on something – anything – other than the shot they were being given.
By Heather Mack | 04:19 pm | January 25, 2017
San Diego, California-based ResMed, maker of connected respiratory devices, announced strong results for its quarter ending on December 31, with over $530 million in revenue representing a 17 percent increase year over year.
By Heather Mack | 06:14 pm | January 24, 2017
Telehealth platform provider Avizia is stepping into new territory: while the company has hitherto offered only a software platform, the technology company will now offer access to a network of providers.
By Jonah Comstock | 05:53 pm | January 24, 2017
The Chan Zuckerberg Inititative, a philanthropic initiative from Facebook CEO Mark Zuckerberg and his wife Dr.
By Heather Mack | 05:14 pm | January 24, 2017
The state of Idaho will no longer ban women from using telemedicine to receive abortion-inducing medication, following the settlement of a lawsuit filed by Planned Parenthood.
By Heather Mack | 03:48 pm | January 24, 2017
Madison, Wisconsin-based Redox, which makes APIs to create interoperability between healthcare organizations and developers, has raised $9 million in Series B funding in a round led by RRE Ventures.
By Jonah Comstock | 03:23 pm | January 24, 2017
Breathometer, the Mark Cuban-backed digital health startup that makes a smartphone-connected oral health sensor, has settled a suit with the Federal Trade Commission over its first product, a smartphone-connected breathalyzer.
By Heather Mack | 02:12 pm | January 24, 2017
Pharmaceutical company Boehringer Ingelheim is partnering with Inovalon, a data analytics company that provides cloud-based platforms to the healthcare industry to facilitate the shift from volume to value-based care, on behalf of Boehringer Ingelheim’s diabetes alliance with Eli Lilly.